Skip to main content
High RiskFDAfda-F-0362-2019SALMONELLA CONTAMINATION

Pierre Philly Style Cheesesteak Sandwich, item 1125, 12 units packaged per case Net Wt. 4.65 LBS (2.11 kg) KEEP FROZEN

Category
Units Affected
23,362
Recall Date
October 19, 2018
Issuing Agency
Hazard
Salmonella Contamination

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0362-2019.

The ingredient supplier initiated a recall due to the potential contamination of Listeria monocytogenes and Salmonella.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0362-2019.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Tyson Foods Discovery Center or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0362-2019.

Tyson Foods Discovery Center

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Tyson Foods Discovery Center Recall FAQ

Tyson Foods Discovery Center is the subject of a dairy safety report: Pierre Philly Style Cheesesteak Sandwich, item 1125, 12 units packaged per case Net Wt. 4.65 LBS (2.11 kg) KEEP FROZEN. The notice was published on October 19, 2018 by the U.S. Food and Drug Administration (FDA). Approximately 23,362 units are potentially affected.